chr5-149981315-TA-T

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong

The NM_000112.4(SLC26A2):​c.1724delA​(p.Lys575fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,614,040 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β˜…β˜…).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000030 ( 0 hom. )

Consequence

SLC26A2
NM_000112.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:12

Conservation

PhyloP100: 0.760
Variant links:
Genes affected
SLC26A2 (HGNC:10994): (solute carrier family 26 member 2) The diastrophic dysplasia sulfate transporter is a transmembrane glycoprotein implicated in the pathogenesis of several human chondrodysplasias. It apparently is critical in cartilage for sulfation of proteoglycans and matrix organization. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 4 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-149981315-TA-T is Pathogenic according to our data. Variant chr5-149981315-TA-T is described in ClinVar as [Pathogenic]. Clinvar id is 4087.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-149981315-TA-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLC26A2NM_000112.4 linkc.1724delA p.Lys575fs frameshift_variant 3/3 ENST00000286298.5 NP_000103.2 P50443
SLC26A2XM_017009191.3 linkc.1724delA p.Lys575fs frameshift_variant 3/4 XP_016864680.1 P50443

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLC26A2ENST00000286298.5 linkc.1724delA p.Lys575fs frameshift_variant 3/31 NM_000112.4 ENSP00000286298.4 P50443
SLC26A2ENST00000503336.1 linkc.372+2966delA intron_variant 3 ENSP00000426053.1 H0YA38

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152218
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000478
AC:
12
AN:
251246
Hom.:
0
AF XY:
0.0000221
AC XY:
3
AN XY:
135810
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000301
AC:
44
AN:
1461822
Hom.:
0
Cov.:
35
AF XY:
0.0000385
AC XY:
28
AN XY:
727206
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000128
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000270
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152218
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000302

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Achondrogenesis, type IB Pathogenic:4
Pathogenic, no assertion criteria providedliterature onlyOMIMFeb 01, 1996- -
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Oct 15, 2020- -
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsFeb 29, 2024- -
Pathogenic, no assertion criteria providedclinical testingInstitute of Medical Genetics and Genomics, Sir Ganga Ram HospitalNov 24, 2021The homozygous frameshift deletion variant c.1724delA has been previously reported as c.1751delA by Superti-Furga A et al in 1996 in a Dutch patient. The allele frequency-0.0048% in gnomAD (aggregated) database and 0.0058% in 1000g. Phenotype observed in the proband was cystic hygroma, generalized subcutaneous edema with skin thickening, hypoechogenic area and distorted fetal limbs. Achondrogensis IB is an autosomal recessive disorder. Based on the phenotypic observation and the available literature, we classify this variant as pathogenic. -
Diastrophic dysplasia Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterSep 22, 2024- -
Likely pathogenic, no assertion criteria providedliterature onlyJuha Muilu Group; Institute for Molecular Medicine Finland (FIMM)-- -
Pathogenic, no assertion criteria providedliterature onlyOMIMFeb 01, 1996- -
Diastrophic dysplasia;C0265274:Achondrogenesis, type IB;C1847593:Multiple epiphyseal dysplasia type 4;C1850554:Atelosteogenesis type II Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 10, 2024- -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 14, 2023This sequence change creates a premature translational stop signal (p.Lys575Serfs*10) in the SLC26A2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 165 amino acid(s) of the SLC26A2 protein. This variant is present in population databases (rs749382145, gnomAD 0.008%). This premature translational stop signal has been observed in individual(s) with achondrogenesis, atelosteogenesis, and diastrophic dysplasia (PMID: 7923357, 8528239, 8571951; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 4087). For these reasons, this variant has been classified as Pathogenic. -
Atelosteogenesis type II Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMFeb 01, 1996- -
Sulfate transporter-related osteochondrodysplasia Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 26, 2017Variant summary: The SLC26A2 c.1724delA (p.Lys575Serfs) variant results in a premature termination codon, predicted to cause a truncated or absent SLC26A2 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. One in silico tool predicts a damaging outcome for this variant. This variant is absent in 121446 control chromosomes. This variant has been reported in multiple affected individuals and classified as pathogenic/likely pathogenic by clinical diagnostic laboratories and reputable databases. Taken together, this variant is classified as pathogenic. -
Connective tissue disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenMay 01, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs386833498; hg19: chr5-149360878; API